BridgeBio Oncology Therapeutics, Inc. SEC filings BBOT
BridgeBio Oncology Therapeutics, Inc. has 185 filings in SEC EDGAR's recent list, going back to Dec 20, 2023. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 23, 2026 | Oct 21, 2026 |
| 4 | Insider transaction | Oct 5, 2026 | Oct 1, 2026 |
| 4 | Insider transaction | Oct 5, 2026 | Oct 1, 2026 |
| 4 | Insider transaction | Oct 5, 2026 | Oct 1, 2026 |
| 4 | Insider transaction | Oct 5, 2026 | Oct 1, 2026 |
| 4 | Insider transaction | Sep 14, 2026 | Sep 10, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jul 1, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 6, 2026 | — |
| 4 | Insider transaction | Jul 6, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | May 12, 2026 | May 10, 2026 |
| 4 | Insider transaction | May 12, 2026 | May 10, 2026 |
| 4 | Insider transaction | May 5, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | May 5, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | May 5, 2026 | Apr 1, 2026 |
| 3 | Initial insider ownership | Apr 30, 2026 | Apr 21, 2026 |
| 3 | Initial insider ownership | Apr 30, 2026 | Apr 20, 2026 |
| 4 | Insider transaction | Mar 26, 2026 | Mar 24, 2026 |
| 3 | Initial insider ownership | Mar 26, 2026 | Mar 24, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 10, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 10, 2026 |
| 4 | Insider transaction | Mar 12, 2026 | Mar 10, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Dec 12, 2025 | Dec 10, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 13, 2025 | — |
| 4 | Insider transaction | Oct 16, 2025 | Oct 10, 2025 |
| 4 | Insider transaction | Oct 6, 2025 | Oct 2, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 3, 2025 | — |
| 4 | Insider transaction | Aug 28, 2025 | Aug 26, 2025 |
| 4 | Insider transaction | Aug 28, 2025 | Aug 26, 2025 |
| 4 | Insider transaction | Aug 28, 2025 | Aug 26, 2025 |
| 4 | Insider transaction | Aug 28, 2025 | Aug 26, 2025 |
| 4 | Insider transaction | Aug 28, 2025 | Aug 26, 2025 |
| 4 | Insider transaction | Aug 28, 2025 | Aug 26, 2025 |
| 4 | Insider transaction | Aug 28, 2025 | Aug 26, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 18, 2025 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Aug 18, 2025 | — |
| 3 | Initial insider ownership | Aug 18, 2025 | Aug 11, 2025 |
| 3 | Initial insider ownership | Aug 18, 2025 | Aug 11, 2025 |
| 3 | Initial insider ownership | Aug 18, 2025 | Aug 11, 2025 |
| 3 | Initial insider ownership | Aug 18, 2025 | Aug 11, 2025 |
| 3 | Initial insider ownership | Aug 18, 2025 | Aug 11, 2025 |
| 3 | Initial insider ownership | Aug 18, 2025 | Aug 11, 2025 |
| 3 | Initial insider ownership | Aug 18, 2025 | Aug 11, 2025 |
| 3 | Initial insider ownership | Aug 18, 2025 | Aug 11, 2025 |
| 3 | Initial insider ownership | Aug 18, 2025 | Aug 11, 2025 |
| 3 | Initial insider ownership | Aug 18, 2025 | Aug 11, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 13, 2025 | — |
| 4 | Insider transaction | Aug 13, 2025 | Aug 11, 2025 |
| 3 | Initial insider ownership | Aug 11, 2025 | Aug 11, 2025 |
| 4 | Insider transaction | Aug 11, 2025 | Aug 11, 2025 |
| 4 | Insider transaction | Aug 11, 2025 | Aug 11, 2025 |
| 4 | Insider transaction | Aug 11, 2025 | Aug 11, 2025 |
| 4 | Insider transaction | Aug 11, 2025 | Aug 11, 2025 |
| 4 | Insider transaction | Aug 11, 2025 | Aug 11, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 30, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 24, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 22, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 15, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 4, 2025 | — |
| 3 | Initial insider ownership | Feb 11, 2025 | Feb 8, 2025 |
| 4 | Insider transaction | Feb 10, 2025 | Feb 8, 2025 |
| 4 | Insider transaction | Feb 10, 2025 | Feb 8, 2025 |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 22, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 23, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 23, 2024 | — |
| SC 13D | Ownership over 5% (active) | Feb 20, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 15, 2024 | — |
| 4 | Insider transaction | Feb 13, 2024 | Feb 13, 2024 |
| 4 | Insider transaction | Feb 13, 2024 | Feb 13, 2024 |
| 3 | Initial insider ownership | Feb 9, 2024 | Feb 8, 2024 |
| 3 | Initial insider ownership | Feb 9, 2024 | Feb 8, 2024 |
| 3 | Initial insider ownership | Feb 9, 2024 | Feb 8, 2024 |
| 3 | Initial insider ownership | Feb 8, 2024 | Feb 8, 2024 |
| 3 | Initial insider ownership | Feb 8, 2024 | Feb 8, 2024 |
| 3 | Initial insider ownership | Feb 8, 2024 | Feb 8, 2024 |
Showing 88 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BBOT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1869105
- Former names
- Helix Acquisition Corp. II (until Aug 6, 2025)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.